Morgan Stanley Maintains Overweight on Nike, Raises Price Target to $140
Morgan Stanley analyst Alexandra Steiger maintains Nike (NYSE:NKE) with a Overweight and raises the price target from $138 to $140.
Morgan Stanley Maintains Equal-Weight on Ulta Beauty, Raises Price Target to $535
Morgan Stanley analyst Simeon Gutman maintains Ulta Beauty (NASDAQ:ULTA) with a Equal-Weight and raises the price target from $510 to $535.
Oppenheimer Maintains Outperform on Coinbase Glb, Lowers Price Target to $70
Oppenheimer analyst Owen Lau maintains Coinbase Glb (NASDAQ:COIN) with a Outperform and lowers the price target from $84 to $70.
Raymond James Maintains Outperform on Aris Water Solutions, Lowers Price Target to $15
Raymond James analyst Justin Jenkins maintains Aris Water Solutions (NYSE:ARIS) with a Outperform and lowers the price target from $20 to $15.
Needham Reiterates Buy on SentinelOne, Maintains $19 Price Target
Needham analyst Alex Henderson reiterates SentinelOne (NYSE:S) with a Buy and maintains $19 price target.
EF Hutton Reiterates Buy on Medalist Diversified REIT, Maintains $1.25 Price Target
EF Hutton analyst Gaurav Mehta reiterates Medalist Diversified REIT (NASDAQ:MDRR) with a Buy and maintains $1.25 price target.
Needham Reiterates Strong Buy on Infinera, Maintains $15 Price Target
Needham analyst Alex Henderson reiterates Infinera (NASDAQ:INFN) with a Strong Buy and maintains $15 price target.
Wedbush Maintains Outperform on Darden Restaurants, Raises Price Target to $165
Wedbush analyst Nick Setyan maintains Darden Restaurants (NYSE:DRI) with a Outperform and raises the price target from $160 to $165.
Evercore ISI Group Initiates Coverage On GE HealthCare Techs with Outperform Rating, Announces Price Target of $90
Evercore ISI Group analyst Vijay Kumar initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Outperform rating and announces Price Target of $90.
Baird Upgrades Truist Finl to Outperform, Announces $53 Price Target
Baird analyst David George upgrades Truist Finl (NYSE:TFC) from Neutral to Outperform and announces $53 price target.